Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cure of leukemia.

M K Brenner1, D Pinkel

  • 1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA.

Seminars in Hematology
|December 14, 1999
PubMed
Summary
This summary is machine-generated.

Significant progress has been made in treating childhood leukemia, but adult leukemia treatments remain challenging. Future research must focus on developing safer, more affordable, and effective leukemia therapies.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

A whole blood model of thrombocytopenia that controls platelet count and hematocrit.

Annals of hematology·2016
Same author

Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor.

Leukemia & lymphoma·2016
Same author

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD.

Bone marrow transplantation·2014
Same author

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.

Bone marrow transplantation·2013
Same author

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals.

Gene therapy·2013
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Leukemia treatment has advanced significantly this century.
  • Combination therapies and stem-cell transplantation have improved outcomes for childhood acute lymphoblastic leukemia (ALL).

Observation:

  • Childhood ALL cure rates exceed 70% in many centers.
  • Adult ALL and other leukemia types still have much lower cure rates.
  • Current therapies are complex, expensive, and toxic, limiting global access and patient desirability.

Findings:

  • Despite progress, significant challenges persist in leukemia treatment.
  • Existing treatments are not universally accessible or desirable due to cost and toxicity.

Implications:

  • Future research should leverage molecular understanding to create safer, cheaper, and more effective leukemia treatments.
  • Developing novel approaches is crucial for addressing unmet needs in leukemia care worldwide.